Follow the Bausch + Lomb Corporation share price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares trade on CA CA, under the supervision of SEDI. Operating in the Health Care sector, Bausch + Lomb Corporation has published 13 reports. Market capitalisation: €4.6bn. The latest transaction was reported on 16 June 2026 (57 - Exercise of rights). Among the most active insiders: Bonnefoy, Luc. All data is openly available.
13
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,985 of 26,132 companies
27.3
score / 100
Value
24
Quality
31
FCF yld-0.8%
Earn yld-4.3%
EV/EBITDA25.5x
ROE-3.3%
Gross mgn60%
Net mgn-7.1%
Debt/EBITDA9.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.